YOU WONT BELIEVE: Charles river laboratories - You Need To See This

Is Charles River Laboratories Stock Outperforming the S&P 500?

Charles River Laboratories has outperformed the broader market over the past year, while analysts remain bullish on the company’s outlook.

Barchart · Sep 27

Is Wall Street Bullish or Bearish on Charles River Laboratories Stock?

Charles River Laboratories has significantly outperformed the market, while strong guidance and a bullish analyst outlook support continued optimism.

Barchart · Aug 26

Charles River Laboratories Earnings Preview: What to Expect

Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit drop in the company’s bottom-line figure.

Barchart · Jul 20

Is Charles River Laboratories Stock Underperforming the Nasdaq?

Charles River Laboratories has significantly underperformed the Nasdaq Composite over the past year, yet analysts remain cautiously optimistic about the stock’s prospects.

Barchart · Sep 24, 2025

Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing

Charles River Laboratories International Inc. (NYSE:CRL) stock is trading lower on Wednesday after the company released second-quarter 2025 earnings.

Benzinga · Aug 6, 2025

Here's What to Expect From Charles River Laboratories' Next Earnings Report

Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit drop in the company’s bottom-line figure.

Barchart · Jul 18, 2025

Is Charles River Laboratories Stock Underperforming the S&P 500?

Despite Charles River Laboratories' weak performance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about its prospects.

Barchart · Jun 25, 2025

Earnings Preview: What To Expect From Charles River Laboratories' Report

Charles River Laboratories is scheduled to announce its first-quarter results next week, with analysts anticipating a single-digit earnings dip.

Barchart · Apr 28, 2025

The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?

Amid market turbulence and policy shifts, do two of the S&P 500’s steepest decliners, DECK and CRL, offer deep value or signal deeper trouble ahead?

MarketBeat · Apr 16, 2025

Charles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish?

Charles River Laboratories has lagged behind the broader market over the past year, with Wall Street analysts maintaining a cautious outlook on its future performance.

Barchart · Feb 26, 2025